Table 3. General recommendations for screening and follow-up of kidney disease in patients with HIV infection.
Assessment | At HIV infection diagnosis and initiation of ART | Follow-up |
---|---|---|
Risk assessment | + | Every visit*, as needed** |
Lifestyle optimization | + | Every visit |
Urine analysis | + | Annually |
Proteinuria (dipstick) | +*** | Annually |
Serum creatinine | + | Annually or more frequently, if indicated |
Estimated GFR (CKD-EPI formula) | + | 3-12 months |
ART – antiretroviral therapy; CKD – chronic kidney disease; GRF – glomerular filtration rate.
A visit is defined as a regular consult with an ID specialist, which may occur every 6 months, or sooner if medically-indicated.
CKD risk factors and treatment with ARV agent with potential nephrotoxicity; the D:A:D score recommended for renal risk assessment (medium risk 0-4, high risk >5).
If dipstick test for proteinuria is positive, recommend urinary protein/creatinine ratio.